PET-CT in the Evaluation of Neoadjuvant/Adjuvant Treatment Response of Soft-tissue Sarcomas: A Comprehensive Review of the Literature.
Samy Castillo-FloresMarcos R GonzalezMayte Bryce-AlbertiFelipe Ferreira de SouzaTy K SubhawongRuss A KukerJuan Pretell-MazziniPublished in: JBJS reviews (2022)
PET-CT limitations such as difficult differentiation between benign inflammatory and malignant processes, inefficient discrimination between benign soft-tissue tumors and STSs, and low sensitivity when evaluating small pulmonary metastases must be of special consideration.